384 related articles for article (PubMed ID: 23944362)
1. Advances in targeting insulin-like growth factor signaling pathway in cancer treatment.
You L; Liu C; Tang H; Liao Y; Fu S
Curr Pharm Des; 2014; 20(17):2899-911. PubMed ID: 23944362
[TBL] [Abstract][Full Text] [Related]
2. State of the art and future perspectives for the use of insulin-like growth factor receptor 1 (IGF-1R) targeted treatment strategies in solid tumors.
Scartozzi M; Bianconi M; Maccaroni E; Giampieri R; Del Prete M; Berardi R; Cascinu S
Discov Med; 2011 Feb; 11(57):144-53. PubMed ID: 21356169
[TBL] [Abstract][Full Text] [Related]
3. Can we unlock the potential of IGF-1R inhibition in cancer therapy?
King H; Aleksic T; Haluska P; Macaulay VM
Cancer Treat Rev; 2014 Oct; 40(9):1096-105. PubMed ID: 25123819
[TBL] [Abstract][Full Text] [Related]
4. Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: a review.
Ozkan EE
Mol Cell Endocrinol; 2011 Sep; 344(1-2):1-24. PubMed ID: 21782884
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between IGF-1R and other tumor promoting pathways.
Liu C; Zhang Z; Tang H; Jiang Z; You L; Liao Y
Curr Pharm Des; 2014; 20(17):2912-21. PubMed ID: 23944361
[TBL] [Abstract][Full Text] [Related]
6. Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer.
Singh P; Alex JM; Bast F
Med Oncol; 2014 Jan; 31(1):805. PubMed ID: 24338270
[TBL] [Abstract][Full Text] [Related]
7. Insulin-Like Growth Factor (IGF) family and prostate cancer.
Gennigens C; Menetrier-Caux C; Droz JP
Crit Rev Oncol Hematol; 2006 May; 58(2):124-45. PubMed ID: 16387509
[TBL] [Abstract][Full Text] [Related]
8. Targeted therapy of the insulin-like growth factor-1 receptor in cancer.
Paz K; Hadari YR
Comb Chem High Throughput Screen; 2008 Jan; 11(1):62-9. PubMed ID: 18220543
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy.
Hua H; Kong Q; Yin J; Zhang J; Jiang Y
J Hematol Oncol; 2020 Jun; 13(1):64. PubMed ID: 32493414
[TBL] [Abstract][Full Text] [Related]
10. Targeting insulin-like growth factor axis in hepatocellular carcinoma.
Wu J; Zhu AX
J Hematol Oncol; 2011 Jul; 4():30. PubMed ID: 21729319
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors in cancer therapy: advances and perspectives.
Xue M; Cao X; Zhong Y; Kuang D; Liu X; Zhao Z; Li H
Curr Pharm Des; 2012; 18(20):2901-13. PubMed ID: 22571659
[TBL] [Abstract][Full Text] [Related]
12. Targeting insulin-like growth factor in breast cancer therapeutics.
Karamouzis MV; Papavassiliou AG
Crit Rev Oncol Hematol; 2012 Oct; 84(1):8-17. PubMed ID: 22424863
[TBL] [Abstract][Full Text] [Related]
13. Novel mechanisms of regulation of IGF-1R action: functional and therapeutic implications.
Worrall C; Nedelcu D; Serly J; Suleymanova N; Oprea I; Girnita A; Girnita L
Pediatr Endocrinol Rev; 2013 Jul; 10(4):473-84. PubMed ID: 23957198
[TBL] [Abstract][Full Text] [Related]
14. Defining the pathway to insulin-like growth factor system targeting in cancer.
Rosenzweig SA; Atreya HS
Biochem Pharmacol; 2010 Oct; 80(8):1115-24. PubMed ID: 20599789
[TBL] [Abstract][Full Text] [Related]
15. The insulin-like growth factor pathway as a target for cancer therapy.
López-Calderero I; Sánchez Chávez E; García-Carbonero R
Clin Transl Oncol; 2010 May; 12(5):326-38. PubMed ID: 20466617
[TBL] [Abstract][Full Text] [Related]
16. Molecular Pathways: Clinical Applications and Future Direction of Insulin-like Growth Factor-1 Receptor Pathway Blockade.
Iams WT; Lovly CM
Clin Cancer Res; 2015 Oct; 21(19):4270-7. PubMed ID: 26429980
[TBL] [Abstract][Full Text] [Related]
17. The insulin-like growth factor 1 receptor in cancer: old focus, new future.
Hartog H; Wesseling J; Boezen HM; van der Graaf WT
Eur J Cancer; 2007 Sep; 43(13):1895-904. PubMed ID: 17624760
[TBL] [Abstract][Full Text] [Related]
18. Targeting insulin-like growth factor type 1 receptor in cancer therapy.
Atzori F; Traina TA; Ionta MT; Massidda B
Target Oncol; 2009 Dec; 4(4):255-66. PubMed ID: 19876700
[TBL] [Abstract][Full Text] [Related]
19. IGF-1R as an anti-cancer target--trials and tribulations.
Chen HX; Sharon E
Chin J Cancer; 2013 May; 32(5):242-52. PubMed ID: 23601239
[TBL] [Abstract][Full Text] [Related]
20. Treatment of hematologic malignancies and solid tumors by inhibiting IGF receptor signaling.
Mitsiades CS; Mitsiades N
Expert Rev Anticancer Ther; 2005 Jun; 5(3):487-99. PubMed ID: 16001956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
